Starting from the notion that Aβ and tau pathology start their accumulation before the appearance of the cognitive impairment associated with AD [141], the research in this field has been conducted not only in full-blown AD but it has been widely extended to healthy aging. Here, MAPT is linked to Alzheimer disease.